Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression
2024 · Annals of the Rheumatic Diseases · 27 citations
https://doi.org/10.1136/ard-2023-224919